Together, our findings suggest that pCAP-250 inhibits LOH and reactivates mutp53, leading to activation of p53 transcriptional targets, enhanced DNA repair, enhanced genomic stability, reduced mitochondrial metabolism, decrease in senescence phenotype and attenuated migration of cancer cells. Here, TP53 is linked to cancer.